• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

    1/23/24 11:52:30 AM ET
    $IBTX
    Major Banks
    Finance
    Get the next $IBTX alert in real time by email
    SC 13G/A 1 us45384b1061_012324.txt us45384b1061_012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 7) Independent Bank Group Inc -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 45384B106 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 45384B106 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 5858941 (6) Shared voting power 0 (7) Sole dispositive power 5980631 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 5980631 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 14.5% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- Independent Bank Group Inc Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 7777 HENNEMAN WAY McKinney TX 75070 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 5980631 Percent of class 14.5% Number of shares as to which such person has: Sole power to vote or to direct the vote 5858941 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 5980631 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of Independent Bank Group Inc is more than five percent of the total outstanding common stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 23, 2024 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Advisors, LLC Aperio Group, LLC BlackRock (Netherlands) B.V. BlackRock Fund Advisors* BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock Investment Management (Australia) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BlackRock, Inc., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Daniel Goldmintz, Laura Hildner, Elizabeth Kogut, David Maryles, Christopher Meade, Una Neary, Charles Park, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 2nd day of January, 2019 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 30th day of April, 2023. BlackRock, Inc. By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary
    Get the next $IBTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IBTX

    DatePrice TargetRatingAnalyst
    5/31/2024$38.00 → $58.00Underweight → Overweight
    Piper Sandler
    4/24/2024$53.00 → $46.00Market Perform
    Hovde Group
    4/24/2024$48.00 → $38.00Neutral → Underweight
    Piper Sandler
    1/5/2024$56.00Mkt Perform → Outperform
    Raymond James
    7/26/2023$40.00 → $44.00Overweight → Neutral
    Piper Sandler
    10/26/2022$82.50 → $70.00Outperform → Market Perform
    Hovde Group
    3/9/2022Neutral
    Janney
    1/26/2022$80.00 → $85.00Buy
    Truist Securities
    More analyst ratings

    $IBTX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SouthState Closes Merger with Independent Financial

      Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState" or the "Company") today announced the closing of its acquisition of Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Financial") on January 1, 2025, through the merger of Independent Financial with and into SouthState. Immediately after the merger, also on January 1, 2025, Independent Financial's subsidiary bank, Independent Bank, merged with and into SouthState Bank, N.A. ("SouthState Bank"). As a result of these transactions, the combined company has expanded its presence in Texas, entered Colorado, and increased its asset size to

      1/2/25 8:00:00 AM ET
      $IBTX
      $SSB
      Major Banks
      Finance
    • Acadia Pharmaceuticals Set to Join S&P SmallCap 600

      NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 3, 2025 S&P SmallCap 600 Addition Acadia Pharmaceuticals ACAD Health Care Jan 3, 2025 S&P SmallCap 600 Deletion Independent Bank Group

      12/30/24 5:37:00 PM ET
      $ACAD
      $IBTX
      $SPGI
      $SSB
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Banks
      Finance
    • Independent Bank Group, Inc. Reports Third Quarter Financial Results and Declares Quarterly Dividend

      Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $20.4 million, or $0.49 per diluted share, for the quarter ended September 30, 2024, compared to $32.8 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and net loss of $493,455 or ($11.93) per diluted share for the quarter ended June 30, 2024. Adjusted (non-GAAP) net income for the quarter ended September 30, 2024 was $20.6 million, or $0.50 per diluted share, compared to $32.6 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and $24.9 million, or $0.60 per diluted share for the quarter ended June 30, 2024. The Company also announced that its Board of Directors d

      10/21/24 5:00:00 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Financials

    Live finance-specific insights

    See more
    • SouthState Corporation to Acquire Texas-based Independent Bank Group, Inc.

      WINTER HAVEN, Fla. and MCKINNEY, Texas, May 20, 2024 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState") and Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Bank Group") jointly announced today that they have entered into a definitive agreement under which SouthState will acquire Independent Bank Group, in an all-stock transaction valued at approximately $2 billion. Independent Bank Group, based in McKinney, Texas, has approximately $18.9 billion in total assets, $15.7 billion in total deposits and $14.6 billion in total loans as of March 31, 2024, and op

      5/20/24 7:00:00 AM ET
      $IBTX
      $SSB
      Major Banks
      Finance
    • Independent Bank Group, Inc. Reports First Quarter Financial Results and Declares Quarterly Dividend

      Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $24.2 million, or $0.58 per diluted share, for the quarter ended March 31, 2024, compared to $14.9 million, or $0.36 per diluted share for the quarter ended December 31, 2023. Adjusted (non-GAAP) net income for the quarter ended March 31, 2024 was $26.0 million, or $0.63 per diluted share, compared to $25.5 million, or $0.62 per diluted share for the quarter ended December 31, 2023. The Company also announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share of common stock. The dividend will be payable on May 16, 2024 to stockholders of record as of the close of business on May 2, 202

      4/22/24 5:00:00 PM ET
      $IBTX
      Major Banks
      Finance
    • Independent Bank Group, Inc. Announces Date for Q1 2024 Earnings Call

      Independent Bank Group, Inc. (NASDAQ:IBTX), the holding company for Independent Financial, will hold a conference call to discuss first quarter 2024 results on Tuesday, April 23, 2024, at 8:30 am ET. The related press release will be issued Monday, April 22, 2024, after 4:00 pm ET. Conference Call Details The call can be accessed by the webcast link, https://www.webcast-eqs.com/indepbankgroupq12024_en/en, or by calling 1-877-407-0989 and by identifying the meeting number 13745780 or by identifying "Independent Bank Group First Quarter 2024 Earnings Conference Call". The conference materials will also be available by accessing the Investor Relations page of our website, www.ifinancial.co

      4/9/24 5:32:00 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

      SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)

      2/13/24 5:06:20 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

      SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)

      2/9/24 5:46:33 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

      SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)

      2/9/24 9:16:05 AM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Leadership Updates

    Live Leadership Updates

    See more
    • SouthState Closes Merger with Independent Financial

      Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState" or the "Company") today announced the closing of its acquisition of Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Financial") on January 1, 2025, through the merger of Independent Financial with and into SouthState. Immediately after the merger, also on January 1, 2025, Independent Financial's subsidiary bank, Independent Bank, merged with and into SouthState Bank, N.A. ("SouthState Bank"). As a result of these transactions, the combined company has expanded its presence in Texas, entered Colorado, and increased its asset size to

      1/2/25 8:00:00 AM ET
      $IBTX
      $SSB
      Major Banks
      Finance
    • Acadia Pharmaceuticals Set to Join S&P SmallCap 600

      NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 3, 2025 S&P SmallCap 600 Addition Acadia Pharmaceuticals ACAD Health Care Jan 3, 2025 S&P SmallCap 600 Deletion Independent Bank Group

      12/30/24 5:37:00 PM ET
      $ACAD
      $IBTX
      $SPGI
      $SSB
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Banks
      Finance
    • Independent Bank Group, Inc. Reports Third Quarter Financial Results and Declares Quarterly Dividend

      Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $20.4 million, or $0.49 per diluted share, for the quarter ended September 30, 2024, compared to $32.8 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and net loss of $493,455 or ($11.93) per diluted share for the quarter ended June 30, 2024. Adjusted (non-GAAP) net income for the quarter ended September 30, 2024 was $20.6 million, or $0.50 per diluted share, compared to $32.6 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and $24.9 million, or $0.60 per diluted share for the quarter ended June 30, 2024. The Company also announced that its Board of Directors d

      10/21/24 5:00:00 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    SEC Filings

    See more
    • SEC Form 15-12G filed by Independent Bank Group Inc

      15-12G - Independent Bank Group, Inc. (0001564618) (Filer)

      1/13/25 5:11:51 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form 15-12G filed by Independent Bank Group Inc

      15-12G - Independent Bank Group, Inc. (0001564618) (Filer)

      1/13/25 5:09:11 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form 15-12G filed by Independent Bank Group Inc

      15-12G - Independent Bank Group, Inc. (0001564618) (Filer)

      1/13/25 5:08:34 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Viola Michael T returned 31,922 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Independent Bank Group, Inc. (0001564618) (Issuer)

      1/3/25 11:17:48 AM ET
      $IBTX
      Major Banks
      Finance
    • Director Washington Paul returned 5,029 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Independent Bank Group, Inc. (0001564618) (Issuer)

      1/3/25 11:16:30 AM ET
      $IBTX
      Major Banks
      Finance
    • Director Poarch Donald L returned 147,508 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Independent Bank Group, Inc. (0001564618) (Issuer)

      1/3/25 11:15:19 AM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Independent Bank Group upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Independent Bank Group from Underweight to Overweight and set a new price target of $58.00 from $38.00 previously

      5/31/24 7:42:54 AM ET
      $IBTX
      Major Banks
      Finance
    • Hovde Group reiterated coverage on Independent Bank Group with a new price target

      Hovde Group reiterated coverage of Independent Bank Group with a rating of Market Perform and set a new price target of $46.00 from $53.00 previously

      4/24/24 6:41:00 AM ET
      $IBTX
      Major Banks
      Finance
    • Independent Bank Group downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Independent Bank Group from Neutral to Underweight and set a new price target of $38.00 from $48.00 previously

      4/24/24 6:16:27 AM ET
      $IBTX
      Major Banks
      Finance